生物谷
(920266)
| 流通市值：8.44亿 | | | 总市值：8.83亿 |
| 流通股本：1.18亿 | | | 总股本：1.24亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 200,815,170.91 | 94,694,477.82 | 432,995,308.51 | 304,011,258.04 |
| 营业总成本 | 210,053,857.52 | 99,824,794.56 | 475,523,555.5 | 340,773,972.13 |
| 其他经营收益 | | | | |
| 营业利润 | -5,197,193.14 | -4,724,162.49 | -42,531,637.81 | -33,618,960.84 |
| 利润总额 | -5,294,298.34 | -4,724,212.23 | -48,214,077.8 | -33,911,861.56 |
| 净利润 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -4,415,627.43 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 431,020,544.75 | 457,987,205.57 | 465,948,857.22 | 479,774,407.59 |
| 非流动资产: | | | | |
| 非流动资产合计 | 588,790,260.52 | 594,106,439.16 | 595,276,506.9 | 595,279,587.2 |
| 资产总计 | 1,019,810,805.27 | 1,052,093,644.73 | 1,061,225,364.12 | 1,075,053,994.79 |
| 流动负债: | | | | |
| 流动负债合计 | 68,815,826.15 | 98,821,874.07 | 107,685,724.61 | 110,817,960.49 |
| 非流动负债: | | | | |
| 非流动负债合计 | 74,608,184.17 | 77,164,533.27 | 72,737,217.13 | 74,667,416.21 |
| 负债合计 | 143,424,010.32 | 175,986,407.34 | 180,422,941.74 | 185,485,376.7 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 876,386,794.95 | 876,107,237.39 | 880,802,422.38 | 889,568,618.09 |
| 股东权益合计 | 876,386,794.95 | 876,107,237.39 | 880,802,422.38 | 889,568,618.09 |
| 负债和股东权益合计 | 1,019,810,805.27 | 1,052,093,644.73 | 1,061,225,364.12 | 1,075,053,994.79 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 245,139,775.36 | 154,326,825.54 | 444,148,667.54 | 314,921,317.3 |
| 经营活动现金流出小计 | 225,659,287.42 | 105,772,652.61 | 502,321,800.12 | 375,296,290.76 |
| 经营活动产生的现金流量净额 | 19,480,487.94 | 48,554,172.93 | -58,173,132.58 | -60,374,973.46 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 173,084,479.62 | 72,270,555.47 | 175,521,724.55 | 95,318,853.31 |
| 投资活动现金流出小计 | 217,829,254.24 | 154,269,629.97 | 96,367,588.19 | 13,048,692.37 |
| 投资活动产生的现金流量净额 | -44,744,774.62 | -81,999,074.5 | 79,154,136.36 | 82,270,160.94 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 246,614.9 | 0 | 7,545,088.41 | 242,185.9 |
| 筹资活动现金流出小计 | 22,478,191 | 2,359,620.38 | 40,033,205.61 | 18,241,658.86 |
| 筹资活动产生的现金流量净额 | -22,231,576.1 | -2,359,620.38 | -32,488,117.2 | -17,999,472.96 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -47,495,862.78 | -35,804,521.95 | -11,507,113.42 | 3,895,714.52 |
| 期末现金及现金等价物余额 | 42,393,587.27 | 54,084,928.1 | 89,889,450.05 | 105,292,277.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -47,495,862.78 | - | -11,507,113.42 | - |